BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castagnoli H, Ferrantini C, Coppini R, Passeri A, Baldini K, Berti V, Cecchi F, Olivotto I, Sciagrà R. Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal. Eur J Nucl Med Mol Imaging 2016;43:2413-22. [PMID: 27527796 DOI: 10.1007/s00259-016-3465-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ruddy TD, Tavoosi A, Taqueti VR. Role of nuclear cardiology in diagnosis and risk stratification of coronary microvascular disease. J Nucl Cardiol . [DOI: 10.1007/s12350-022-03051-z] [Reference Citation Analysis]
2 Calabretta R, Kokomani A, Fumagalli C, Olivotto I, Camici PG, Hacker M, Sciagrà R. Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy. J Nucl Cardiol 2022. [PMID: 35112308 DOI: 10.1007/s12350-022-02911-y] [Reference Citation Analysis]
3 Cavigli L, D’ascenzi F, Pelliccia A, Cecchi F. Hypertrophic Cardiomyopathy and Left Ventricular Non-Compaction. Sport-related sudden cardiac death 2022. [DOI: 10.1007/978-3-030-80447-3_4] [Reference Citation Analysis]
4 Sohn JH, Behr SC, Hernandez Pampaloni M, Seo Y. Quantitative Assessment of Myocardial Ischemia With Positron Emission Tomography. J Thorac Imaging 2021. [PMID: 33492046 DOI: 10.1097/RTI.0000000000000579] [Reference Citation Analysis]
5 Sciagrà R, Lubberink M, Hyafil F, Saraste A, Slart RHJA, Agostini D, Nappi C, Georgoulias P, Bucerius J, Rischpler C, Verberne HJ; Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 2021;48:1040-69. [PMID: 33135093 DOI: 10.1007/s00259-020-05046-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 13.5] [Reference Citation Analysis]
6 Schindler TH, Bateman TM, Berman DS, Chareonthaitawee P, De Blanche LE, Dilsizian V, Dorbala S, Gropler RJ, Shaw L, Soman P, Winchester DE, Verberne H, Ahuja S, Beanlands RS, Di Carli MF, Murthy VL, Ruddy TD, Schwartz RG. Appropriate Use Criteria for PET Myocardial Perfusion Imaging. J Nucl Med 2020;61:1221-65. [PMID: 32747510 DOI: 10.2967/jnumed.120.246280] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
7 Magnusson P, Nordström J, Harms HJ, Lubberink M, Gadler F, Sörensen J, Mörner S. Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. Int J Cardiol Heart Vasc 2020;26:100452. [PMID: 32140548 DOI: 10.1016/j.ijcha.2019.100452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Camaioni C, Knott KD, Augusto JB, Seraphim A, Rosmini S, Ricci F, Boubertakh R, Xue H, Hughes R, Captur G, Lopes LR, Brown LAE, Manisty C, Petersen SE, Plein S, Kellman P, Mohiddin SA, Moon JC. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy. Heart 2020;106:824-9. [PMID: 31822572 DOI: 10.1136/heartjnl-2019-315848] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
9 Sciagrà R. Microvascular Dysfunction in Hypertrophic Cardiomyopathy. Curr Cardiovasc Imaging Rep 2019;12. [DOI: 10.1007/s12410-019-9478-4] [Reference Citation Analysis]
10 Kay GN. Can positron emission tomography help stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy? J Nucl Cardiol 2019;26:1135-7. [PMID: 29761308 DOI: 10.1007/s12350-018-1299-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Bravo PE. Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy? J Nucl Cardiol 2019;26:1125-34. [DOI: 10.1007/s12350-018-1298-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lu DY, Yalçin H, Yalçin F, Zhao M, Sivalokanathan S, Valenta I, Tahari A, Pomper MG, Abraham TP, Schindler TH, Abraham MR. Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol 2018;121:1081-9. [PMID: 29678336 DOI: 10.1016/j.amjcard.2018.01.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
13 Tsai SY, Wang SY, Shiau YC, Wu YW. Mechanical dyssynchrony and diastolic dysfunction are common in LVH: a pilot correlation study using Doppler echocardiography and CZT gated-SPECT MPI. Sci Rep 2018;8:4182. [PMID: 29520004 DOI: 10.1038/s41598-018-22213-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
14 Tower-rader A, Betancor J, Lever HM, Desai MY. A Comprehensive Review of Stress Testing in Hypertrophic Cardiomyopathy: Assessment of Functional Capacity, Identification of Prognostic Indicators, and Detection of Coronary Artery Disease. Journal of the American Society of Echocardiography 2017;30:829-44. [DOI: 10.1016/j.echo.2017.05.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
15 Inubushi M, Kaneta T, Ishimori T, Imabayashi E, Okizaki A, Oku N. Topics of nuclear medicine research in Europe. Ann Nucl Med 2017;31:571-4. [DOI: 10.1007/s12149-017-1198-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Huke S. Linking myofilaments to sudden cardiac death: recent advances. J Physiol 2017;595:3939-47. [PMID: 28205229 DOI: 10.1113/JP273047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]